Back to Search
MARIVIC BOTTA, M.D.
M.D.
Pediatrics Physician
NPI: 1013055102Individual
Specialties, Licenses & Credentials
Research & Publications (20)
New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34(+) cells.
PMID 19629392·Invest New Drugs·2010
8-other
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.
PMID 19299129·Bioorg Med Chem Lett·2009
4-observational
Relaxivity modulation in Gd-functionalised mesoporous silicas.
PMID 19240888·Chem Commun (Camb)·2009
8-other
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
PMID 19581099·Bioorg Med Chem·2009
7-preclinical
Raft component GD3 associates with tubulin following CD95/Fas ligation.
PMID 19509307·FASEB J·2009
8-other
Stereoselective protecting group free synthesis of D,L-gulose ethyl glycoside via multicomponent enyne cross metathesis--hetero Diels-Alder reaction.
PMID 19501816·Carbohydr Res·2009
8-other
Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases.
PMID 19477418·Chem Biol·2009
8-other
Recent highlights in the synthesis of highly functionalized pyrimidines.
PMID 19582291·Org Biomol Chem·2009
6-review
Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
PMID 19447621·Bioorg Med Chem Lett·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15 CORPORATE DR
TRUMBULL, CT 06611 - Phone
- (203) 452-8322
Quick Facts
- NPI
- 1013055102
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile